Invention Grant
US09073888B2 Coumarin compounds as receptor modulators with therapeutic utility
有权
香豆素化合物作为具有治疗效用的受体调节剂
- Patent Title: Coumarin compounds as receptor modulators with therapeutic utility
- Patent Title (中): 香豆素化合物作为具有治疗效用的受体调节剂
-
Application No.: US13502980Application Date: 2010-10-20
-
Publication No.: US09073888B2Publication Date: 2015-07-07
- Inventor: Todd M. Heidelbaugh , John R. Cappiello , Phong X. Nguyen , Dario G. Gomez
- Applicant: Todd M. Heidelbaugh , John R. Cappiello , Phong X. Nguyen , Dario G. Gomez
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Barbara C. Potts
- International Application: PCT/US2010/053363 WO 20101020
- International Announcement: WO2011/050054 WO 20110428
- Main IPC: C07D311/16
- IPC: C07D311/16 ; C07D311/18 ; C07D405/12
Abstract:
The present invention relates to novel 2-oxo-2H-chromene-3-carboxamide derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
Public/Granted literature
- US20120328661A1 COUMARIN COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY Public/Granted day:2012-12-27
Information query
